Sun Pharma looking to divest Ireland plant

Last Updated: Thursday, September 10, 2015, 08:04

"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.

Sun Pharma completes acquisition of GSK Australia opiates biz

Last Updated: Tuesday, September 1, 2015, 13:01

The company has started the integration of opiates business after completion of the deal, which would strengthen its position in global market and expand its narcotics raw material (NRM) market share.

'Indian pharma industry capable of discovering new drugs'

Last Updated: Saturday, August 29, 2015, 20:22

Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today

Sun Pharma US arm faces class action suit from ex-employees

Last Updated: Friday, August 28, 2015, 19:24

Sun Pharmaceutical Industries on Friday said a class action lawsuit has been filed against its US arm by some former employees following the shut down of a manufacturing unit at Detroit in Michigan.

Govt assures all help to boost pharma exports

Last Updated: Tuesday, August 18, 2015, 21:22

Government Tuesday assured the pharma industry of "every possible help" in resolving its issues related to exports and said efforts would be made to expedite work on different proposals to realise the full potential of the sector.

PSUs in pharma sector will not be sold: Ananth Kumar

Last Updated: Wednesday, August 5, 2015, 22:03

Public sector undertakings in pharmaceuticals sector will not be sold but their assets will be leveraged to make them financially viable, the government said today.

India defers FTA talks with EU over ban of 700 pharma products

Last Updated: Wednesday, August 5, 2015, 17:36

Expressing disappointment and concern over the EU banning sale of around 700 pharma products clinically tested by GVK Biosciences, India has deferred the talks with the European Union on the proposed free trade agreement.

SRL lines up Rs 100 crore to add 100 labs by 2016-end

Last Updated: Sunday, August 2, 2015, 13:32

Leading laboratory network SRL Diagnostics is planning to invest around Rs 100 crore to add 100 labs across the country by the end of 2016 as part of its expansion plan.

Hikma buys US generic drugmaker Roxane for $2.65bn

Last Updated: Tuesday, July 28, 2015, 15:59

London-listed pharmaceuticals firm Hikma on Tuesday bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector`s latest rapid round of consolidation.

EU bans 700 generic drugs for manipulation of trials by GVK

Last Updated: Saturday, July 25, 2015, 14:26

The European Union has banned the marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by India's pharmaceutical research company GVK Biosciences.

Lupin on buying spree; to acquire German Co's product portfolio

Last Updated: Friday, July 24, 2015, 22:56

A day after announcing its biggest acquisition deal of USD 880 million, Lupin Friday said it will buy Germany-based Temmler Pharma's specialty product portfolio.

Lupin to buy US-based Gavis Pharmaceuticals for $880 mn

Last Updated: Thursday, July 23, 2015, 16:49

Drug major Lupin Thursday said it is acquiring US-based Gavis for USD 880 million (over Rs 5,610 crore) to consolidate presence in the world's largest pharmaceuticals market.